Indian Pembrolizumab Exporters: Complete Supplier Ranking with Market Share — 34 Manufacturers (2026) — TransData Nexus

Q: Who is the largest pembrolizumab supplier from India?

GNH INDIA PHARMACEUTICALS LIMITED is the largest pembrolizumab exporter from India with a 14.8% market share and export value of $285.3K.

Q: How many pembrolizumab suppliers are there in India?

There are 34 active pembrolizumab exporters in India, collectively shipping $1.9M worth of pembrolizumab across 215 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top pembrolizumab suppliers from India?

The top 5 pembrolizumab suppliers from India — GNH INDIA PHARMACEUTICALS LIMITED, GEMINI HEALTHWORLD LLP, 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, VAMA LIFECARE PRIVATE LIMITED, SHREE KRISHNA LIFECARE — together control 54.6% of total pembrolizumab export value from India.

Suresh Sormare

Pembrolizumab

India Pharmaceutical Trade Intelligence

$1.9M34 Suppliers21 CountriesHS 30021500

ExportsIndia → BRAZIL44.6%India → ZIMBABWE8.5%

ImportsIRELAND → India$2.3B SINGAPORE → India$85.8M

#1 Supplier: GNH INDIA #1 Buyer: INDIRA GANDHI

Pembrolizumab Suppliers from India (2026) — 34 Exporters, $1.9M Market | TransData Nexus | TransData Nexus

Who Exports Pembrolizumab from India — 34 Suppliers Behind a $1.9M Market

India's pembrolizumab export market is supplied by 34 active exporters who collectively shipped $1.9M across 215 shipments. GNH INDIA PHARMACEUTICALS LIMITED leads with a 14.8% market share, followed by GEMINI HEALTHWORLD LLP and 3S PHARMACEUTICALS INDIA PRIVATE LIMITED. The top 5 suppliers together control 54.6% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Pembrolizumab Suppliers & Exporters — 34 manufacturers, $1.9M export market, top destinations and formulations — Pembrolizumab supplier data — 34 exporters · $1.9M market · 215 shipmentsTransData Nexus · Indian Customs Data

Top Pembrolizumab Exporters from India — Ranked by Export Value

GNH INDIA PHARMACEUTICALS LIMITED is the leading pembrolizumab exporter from India, holding a 14.8% share of the $1.9M market across 215 shipments from 34 exporters. The top 5 suppliers — GNH INDIA PHARMACEUTICALS LIMITED, GEMINI HEALTHWORLD LLP, 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, VAMA LIFECARE PRIVATE LIMITED, SHREE KRISHNA LIFECARE — collectively control 54.6% of total export value, indicating a moderately concentrated market. Individual shares are: GNH INDIA PHARMACEUTICALS LIMITED (14.8%), GEMINI HEALTHWORLD LLP (11.0%), 3S PHARMACEUTICALS INDIA PRIVATE LIMITED (10.4%), VAMA LIFECARE PRIVATE LIMITED (9.4%), SHREE KRISHNA LIFECARE (9.0%).

Top Pembrolizumab Exporters from India

Ranked by export value · 34 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Pembrolizumab Exporters from India — Ranked by Export Value. 34 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Pembrolizumab exporters

Certification and compliance status for top Pembrolizumab suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
GNH INDIA PHARMACEUTICALS LIMITED	Not Listed	Yes	No	Not verified	WHO-GDP and ISO 9001:2015 certified pharmaceutical distributor.
KWALITY PHARMACEUTICALS LIMITED	Not Listed	Yes	Yes	Not verified	EU GMP approval for Cephalosporin and Oncology manufacturing unit in April 2023.
SAVIOUR PHARMACEUTICALS	Not Listed	Yes	Yes	Not verified	Operates WHO-GMP approved plant in Gujarat, India, adhering to global standards.

TransData Nexus reviewed the regulatory standing of 3 leading Pembrolizumab exporters from India. 0 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 2 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Pembrolizumab sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs) and bulk drug manufacturing. The city hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. The presence of Genome Valley, India's first biotech cluster, underscores Hyderabad's role in biotech and life sciences innovation. This robust infrastructure and talent pool make Hyderabad a significant contributor to the production of complex biologics such as Pembrolizumab.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its expertise in pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with companies like Zydus Lifesciences and Cadila Pharmaceuticals headquartered in the region. The state's mature pharma ecosystem, supported by strong infrastructure and regulatory compliance, positions it as a leader in the formulation and export of finished pharmaceutical products, including monoclonal antibodies like Pembrolizumab.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Pembrolizumab exporters from India

August 19, 2024

M&A

Vishnu Chemicals Limited — Vishnu Chemicals acquires Jayansree Pharma to enhance specialty chemicals manufacturing

Vishnu Chemicals Limited announced the 100% equity acquisition of Jayansree Pharma Private Limited for a total consideration of INR 51.99 crore. This acquisition aims to bolster Vishnu Chemicals' specialty chemicals manufacturing capabilities, with plans to commence production of strontium carbonate at the acquired plant in Visakhapatnam, Andhra Pradesh. IMPACT: This acquisition is not directly related to Pembrolizumab exports but reflects the ongoing consolidation in the pharmaceutical sector.

Impact: This acquisition is not directly related to Pembrolizumab exports but reflects the ongoing consolidation in the pharmaceutical sector.

September 27, 2024

M&A

SeQuent Scientific Limited — SeQuent Scientific and Viyash Lifesciences merge to form leading animal health venture

SeQuent Scientific Limited and Viyash Lifesciences Private Limited announced a merger to create a platform with leadership in animal pharmaceuticals and expanded capabilities across the global pharmaceutical market. The merger is expected to enhance the combined entity's scale, deepen research and development capabilities, and strengthen its supply chain. IMPACT: This merger focuses on the animal health sector and does not impact Pembrolizumab exports.

Common Questions — Pembrolizumab Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which pembrolizumab supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, GNH INDIA PHARMACEUTICALS LIMITED leads with 6 recorded shipments worth $285.3K. GEMINI HEALTHWORLD LLP (26 shipments) and 3S PHARMACEUTICALS INDIA PRIVATE LIMITED (12 shipments) are also established high-volume exporters.

Q How many pembrolizumab manufacturers are there in India?

India has 34 active pembrolizumab exporters with a combined export market of $1.9M across 215 shipments to 21 countries. The top 5 suppliers hold 54.6% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for pembrolizumab from India?

Average FOB unit price: $1743.00 per unit, ranging from $0.72 to $4672.86. Average shipment value: .

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Pembrolizumab

Pembrolizumab

Who Exports Pembrolizumab from India — 34 Suppliers Behind a $1.9M Market

Top Pembrolizumab Exporters from India — Ranked by Export Value

Top Pembrolizumab Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Vishnu Chemicals Limited — Vishnu Chemicals acquires Jayansree Pharma to enhance specialty chemicals manufacturing

SeQuent Scientific Limited — SeQuent Scientific and Viyash Lifesciences merge to form leading animal health venture

Common Questions — Pembrolizumab Suppliers from India

Q Which pembrolizumab supplier from India is the most reliable for bulk orders?

Q How many pembrolizumab manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for pembrolizumab from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Zydus Lifesciences Limited — Zydus Lifesciences acquires 50% stake in Sterling Biotech for biotech expansion

Analysis Methodology